{
    "id": 31652,
    "fullName": "CDK11B G579S",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "CDK11B G579S lies within the protein kinase domain of the Cdk11b protein (UniProt.org). G579S is associated with resistance to CDK11 inhibitors (PMID: 31511426), but has not been biochemically characterized, and therefore, its effect on Cdk11b protein function is unknown (PubMed, Nov 2019).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 16920,
                    "pubMedId": 31511426,
                    "title": "Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31511426"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 984,
        "geneSymbol": "CDK11B",
        "terms": [
            "CDK11B",
            "CDC2L1",
            "CDK11",
            "CDK11-p110",
            "CDK11-p46",
            "CDK11-p58",
            "CLK-1",
            "p58",
            "p58CDC2L1",
            "p58CLK-1",
            "PITSLREA",
            "PK58"
        ]
    },
    "variant": "G579S",
    "createDate": "11/25/2019",
    "updateDate": "11/25/2019",
    "referenceTranscriptCoordinates": {
        "id": 185646,
        "transcript": "NM_001787",
        "gDna": "chr1:g.1637001C>T",
        "cDna": "c.1735G>A",
        "protein": "p.G579S",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19310,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, introduction of CDK11B G579S into a colon cancer cell line conferred resistance to OTS964 in culture (PMID: 31511426).",
            "molecularProfile": {
                "id": 34027,
                "profileName": "CDK11B G579S"
            },
            "therapy": {
                "id": 5259,
                "therapyName": "OTS964",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 16920,
                    "pubMedId": 31511426,
                    "title": "Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31511426"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34027,
            "profileName": "CDK11B G579S",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 185646,
            "transcript": "NM_001787",
            "gDna": "chr1:g.1637001C>T",
            "cDna": "c.1735G>A",
            "protein": "p.G579S",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}